Cargando…
A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1
• Genomic alterations may improve diagnostic certainty and subsequent treatment of endometrial stromal sarcoma. • Novel JAZF1-BCORL1 mutation was identified. • Targeted therapeutics to down-stream targets may improve survival benefit in these patients.
Autores principales: | Allen, Allison J, Ali, Siraj M., Gowen, Kyle, Elvin, Julia A., Pejovic, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348601/ https://www.ncbi.nlm.nih.gov/pubmed/28331900 http://dx.doi.org/10.1016/j.gore.2017.03.002 |
Ejemplares similares
-
JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas
por: Hrzenjak, Andelko
Publicado: (2016) -
Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling
por: Hasegawa, Chie, et al.
Publicado: (2023) -
RNA-driven JAZF1-SUZ12 gene fusion in human endometrial stromal cells
por: Gupta, Sachin Kumar, et al.
Publicado: (2021) -
The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis
por: Ma, Xianyong, et al.
Publicado: (2016) -
JAZF1–SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report
por: Fujiishi, Koto, et al.
Publicado: (2019)